AVDL logo

Avadel Pharmaceuticals plc (AVDL) EBIT

Annual EBIT:

-$38.25M+$112.64M(+74.65%)
December 31, 2024

Summary

  • As of today, AVDL annual earnings before interest & taxes is -$38.25 million, with the most recent change of +$112.64 million (+74.65%) on December 31, 2024.
  • During the last 3 years, AVDL annual EBIT has risen by +$44.95 million (+54.03%).
  • AVDL annual EBIT is now -140.82% below its all-time high of $93.71 million, reached on December 31, 2017.

Performance

AVDL EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAVDLincome statement metrics

Quarterly EBIT:

$1.94M-$6.95M(-78.20%)
September 30, 2025

Summary

  • As of today, AVDL quarterly earnings before interest & taxes is $1.94 million, with the most recent change of -$6.95 million (-78.20%) on September 30, 2025.
  • Over the past year, AVDL quarterly EBIT has increased by +$2.26 million (+692.35%).
  • AVDL quarterly EBIT is now -93.72% below its all-time high of $30.82 million, reached on June 30, 2015.

Performance

AVDL Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAVDLincome statement metrics

TTM EBIT:

$4.52M+$2.26M(+100.22%)
September 30, 2025

Summary

  • As of today, AVDL TTM earnings before interest & taxes is $4.52 million, with the most recent change of +$2.26 million (+100.22%) on September 30, 2025.
  • Over the past year, AVDL TTM EBIT has increased by +$68.53 million (+107.07%).
  • AVDL TTM EBIT is now -95.58% below its all-time high of $102.40 million, reached on December 31, 2015.

Performance

AVDL TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAVDLincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

AVDL EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+74.7%+692.4%+107.1%
3Y3 Years+54.0%+111.4%+104.8%
5Y5 Years-46.5%+113.8%+115.4%

AVDL EBIT Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+74.7%-78.2%+103.9%at high+103.3%
5Y5-Year-583.4%+74.7%-78.2%+103.9%at high+103.3%
All-TimeAll-Time-140.8%+74.7%-93.7%+103.9%-95.6%+103.3%

AVDL EBIT History

DateAnnualQuarterlyTTM
Sep 2025
-
$1.94M(-78.2%)
$4.52M(+100.2%)
Jun 2025
-
$8.88M(+396.0%)
$2.26M(+111.7%)
Mar 2025
-
-$3.00M(+9.0%)
-$19.37M(+54.3%)
Dec 2024
-$38.25M(+74.7%)
-$3.30M(-908.3%)
-$42.40M(+33.8%)
Sep 2024
-
-$327.00K(+97.4%)
-$64.00M(+35.2%)
Jun 2024
-
-$12.74M(+51.1%)
-$98.79M(+27.1%)
Mar 2024
-
-$26.04M(-4.6%)
-$135.59M(+1.6%)
Dec 2023
-$150.89M(-52.3%)
-$24.90M(+29.1%)
-$137.85M(-1.2%)
Sep 2023
-
-$35.11M(+29.1%)
-$136.16M(-15.3%)
Jun 2023
-
-$49.54M(-75.1%)
-$118.08M(-24.4%)
Mar 2023
-
-$28.30M(-21.9%)
-$94.89M(+0.3%)
Dec 2022
-$99.10M(-19.1%)
-$23.22M(-36.3%)
-$95.22M(-0.1%)
Sep 2022
-
-$17.03M(+35.4%)
-$95.14M(+8.3%)
Jun 2022
-
-$26.34M(+8.0%)
-$103.77M(-4.4%)
Mar 2022
-
-$28.63M(-23.7%)
-$99.36M(-16.1%)
Dec 2021
-$83.20M(-1151.6%)
-$23.14M(+9.8%)
-$85.60M(-11.6%)
Sep 2021
-
-$25.66M(-17.0%)
-$76.72M(-17.9%)
Jun 2021
-
-$21.94M(-47.6%)
-$65.05M(-36.5%)
Mar 2021
-
-$14.86M(-4.2%)
-$47.66M(-30.0%)
Dec 2020
$7.91M(+130.3%)
-$14.26M(-1.9%)
-$36.66M(-24.5%)
Sep 2020
-
-$13.99M(-207.6%)
-$29.45M(-72.1%)
Jun 2020
-
-$4.55M(-17.8%)
-$17.11M(-7.7%)
Mar 2020
-
-$3.86M(+45.2%)
-$15.88M(+5.6%)
Dec 2019
-$26.10M(+74.6%)
-$7.04M(-325.9%)
-$16.83M(+30.1%)
Sep 2019
-
-$1.65M(+50.2%)
-$24.06M(+44.8%)
Jun 2019
-
-$3.32M(+30.9%)
-$43.55M(+22.0%)
Mar 2019
-
-$4.80M(+66.4%)
-$55.85M(+7.8%)
Dec 2018
-$102.58M(-209.5%)
-$14.28M(+32.5%)
-$60.55M(-13.8%)
Sep 2018
-
-$21.14M(-35.3%)
-$53.22M(-224.2%)
Jun 2018
-
-$15.62M(-64.4%)
-$16.41M(-177.5%)
Mar 2018
-
-$9.50M(-36.7%)
$21.17M(-64.5%)
Dec 2017
$93.71M(+1170.4%)
-$6.95M(-144.4%)
$59.70M(-25.4%)
Sep 2017
-
$15.66M(-28.7%)
$80.01M(+15.9%)
Jun 2017
-
$21.96M(-24.3%)
$69.01M(+16.2%)
Mar 2017
-
$29.02M(+117.2%)
$59.40M(+34.0%)
Dec 2016
-$8.76M(-111.3%)
$13.36M(+186.8%)
$44.32M(-21.9%)
Sep 2016
-
$4.66M(-62.3%)
$56.77M(-31.1%)
Jun 2016
-
$12.36M(-11.4%)
$82.42M(-18.3%)
Mar 2016
-
$13.95M(-46.0%)
$100.88M(-1.5%)
Dec 2015
$77.70M(+192.1%)
$25.81M(-14.8%)
$102.40M(+56.3%)
Sep 2015
-
$30.30M(-1.7%)
$65.50M(+149.6%)
Jun 2015
-
$30.82M(+99.3%)
$26.24M(+316.6%)
Mar 2015
-
$15.47M(+239.4%)
-$12.11M(+64.6%)
Dec 2014
-$84.38M(-58.7%)
-$11.10M(-23.9%)
-$34.17M(-1.1%)
Sep 2014
-
-$8.96M(-18.9%)
-$33.80M(-10.4%)
Jun 2014
-
-$7.53M(-14.2%)
-$30.60M(-6.2%)
Mar 2014
-
-$6.59M(+38.5%)
-$28.83M(+1.0%)
Dec 2013
-$53.16M(-468.5%)
-$10.72M(-86.2%)
-$29.11M(-33.4%)
Sep 2013
-
-$5.76M(-0.1%)
-$21.83M(-2.3%)
Jun 2013
-
-$5.75M(+16.3%)
-$21.33M(+1.8%)
Mar 2013
-
-$6.88M(-99.8%)
-$21.73M(-16.9%)
Dec 2012
-$9.35M(-9.9%)
-$3.44M(+34.6%)
-$18.58M(-122.8%)
Sep 2012
-
-$5.26M(+14.4%)
-$8.34M(-354.3%)
Jun 2012
-
-$6.15M(-65.0%)
-$1.84M(-379.0%)
Mar 2012
-
-$3.73M(-154.8%)
$658.00K(+229.8%)
Dec 2011
-$8.51M(+2.7%)
$6.80M(+448.3%)
-$507.00K(+90.4%)
Sep 2011
-
$1.24M(+133.9%)
-$5.26M(+45.4%)
Jun 2011
-
-$3.65M(+25.3%)
-$9.63M(+10.0%)
Mar 2011
-
-$4.89M(-339.2%)
-$10.70M(-8.8%)
DateAnnualQuarterlyTTM
Dec 2010
-$8.74M(+22.9%)
$2.04M(+165.4%)
-$9.84M(-100.7%)
Sep 2010
-
-$3.13M(+33.9%)
-$4.90M(-176.0%)
Jun 2010
-
-$4.73M(-17.3%)
-$1.78M(-160.2%)
Mar 2010
-
-$4.03M(-157.7%)
$2.95M(-57.7%)
Dec 2009
-$11.34M(+2.0%)
$6.98M(>+9900.0%)
$6.98M(>+9900.0%)
Sep 2009
-
$0.00(0.0%)
$0.00(-100.0%)
Jun 2009
-
$0.00(0.0%)
$6.30M(+1009.5%)
Mar 2009
-
$0.00(0.0%)
$568.00K(+113.1%)
Dec 2008
-$11.57M(+71.7%)
$0.00(-100.0%)
-$4.33M(+63.6%)
Sep 2008
-
$6.30M(+209.9%)
-$11.89M(+56.7%)
Jun 2008
-
-$5.73M(-17.1%)
-$27.46M(+23.2%)
Mar 2008
-
-$4.89M(+35.3%)
-$35.73M(+11.5%)
Dec 2007
-$40.85M(-5.2%)
-$7.57M(+18.3%)
-$40.36M(+2.2%)
Sep 2007
-
-$9.26M(+33.9%)
-$41.26M(+3.2%)
Jun 2007
-
-$14.01M(-47.1%)
-$42.64M(-11.6%)
Mar 2007
-
-$9.52M(-12.4%)
-$38.21M(+1.6%)
Dec 2006
-$38.84M(+4.7%)
-$8.47M(+20.5%)
-$38.84M(+6.3%)
Sep 2006
-
-$10.64M(-11.0%)
-$41.46M(+3.6%)
Jun 2006
-
-$9.59M(+5.5%)
-$43.00M(+0.8%)
Mar 2006
-
-$10.14M(+8.5%)
-$43.33M(-6.3%)
Dec 2005
-$40.77M(-561.4%)
-$11.09M(+8.9%)
-$40.77M(-65.3%)
Sep 2005
-
-$12.18M(-22.8%)
-$24.66M(-138.0%)
Jun 2005
-
-$9.92M(-30.8%)
-$10.36M(-309.6%)
Mar 2005
-
-$7.58M(-251.0%)
-$2.53M(-128.6%)
Dec 2004
$8.84M(+288.0%)
$5.02M(+137.1%)
$8.84M(+131.5%)
Sep 2004
-
$2.12M(+201.5%)
$3.82M(+124.6%)
Jun 2004
-
-$2.08M(-155.1%)
$1.70M(-55.1%)
Mar 2004
-
$3.78M(>+9900.0%)
$3.78M(>+9900.0%)
Dec 2003
-$4.70M(-2007.2%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2003
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2003
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2003
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2002
-$223.00K(+92.9%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2002
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2002
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2002
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2001
-$3.15M(+80.4%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2001
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2001
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2001
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2000
-$16.11M(-130.1%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2000
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2000
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2000
-
$0.00(0.0%)
$0.00(0.0%)
Dec 1999
-$7.00M(+24.7%)
$0.00(0.0%)
$0.00(0.0%)
Sep 1999
-
$0.00(0.0%)
$0.00(0.0%)
Jun 1999
-
$0.00(0.0%)
$0.00(0.0%)
Mar 1999
-
$0.00(0.0%)
$0.00(0.0%)
Dec 1998
-$9.29M(-3.2%)
$0.00(0.0%)
$0.00(0.0%)
Sep 1998
-
$0.00(0.0%)
$0.00(0.0%)
Jun 1998
-
$0.00(0.0%)
$0.00(0.0%)
Mar 1998
-
$0.00(0.0%)
$0.00(0.0%)
Dec 1997
-$9.00M(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 1997
-
$0.00(0.0%)
$0.00(0.0%)
Jun 1997
-
$0.00(0.0%)
$0.00(0.0%)
Mar 1997
-
$0.00(0.0%)
$0.00(0.0%)
Dec 1996
-$9.00M
$0.00(0.0%)
$0.00(0.0%)
Sep 1996
-
$0.00(0.0%)
$0.00(0.0%)
Jun 1996
-
$0.00(0.0%)
$0.00(0.0%)
Mar 1996
-
$0.00
$0.00

FAQ

  • What is Avadel Pharmaceuticals plc annual earnings before interest & taxes?
  • What is the all-time high annual EBIT for Avadel Pharmaceuticals plc?
  • What is Avadel Pharmaceuticals plc annual EBIT year-on-year change?
  • What is Avadel Pharmaceuticals plc quarterly earnings before interest & taxes?
  • What is the all-time high quarterly EBIT for Avadel Pharmaceuticals plc?
  • What is Avadel Pharmaceuticals plc quarterly EBIT year-on-year change?
  • What is Avadel Pharmaceuticals plc TTM earnings before interest & taxes?
  • What is the all-time high TTM EBIT for Avadel Pharmaceuticals plc?
  • What is Avadel Pharmaceuticals plc TTM EBIT year-on-year change?

What is Avadel Pharmaceuticals plc annual earnings before interest & taxes?

The current annual EBIT of AVDL is -$38.25M

What is the all-time high annual EBIT for Avadel Pharmaceuticals plc?

Avadel Pharmaceuticals plc all-time high annual earnings before interest & taxes is $93.71M

What is Avadel Pharmaceuticals plc annual EBIT year-on-year change?

Over the past year, AVDL annual earnings before interest & taxes has changed by +$112.64M (+74.65%)

What is Avadel Pharmaceuticals plc quarterly earnings before interest & taxes?

The current quarterly EBIT of AVDL is $1.94M

What is the all-time high quarterly EBIT for Avadel Pharmaceuticals plc?

Avadel Pharmaceuticals plc all-time high quarterly earnings before interest & taxes is $30.82M

What is Avadel Pharmaceuticals plc quarterly EBIT year-on-year change?

Over the past year, AVDL quarterly earnings before interest & taxes has changed by +$2.26M (+692.35%)

What is Avadel Pharmaceuticals plc TTM earnings before interest & taxes?

The current TTM EBIT of AVDL is $4.52M

What is the all-time high TTM EBIT for Avadel Pharmaceuticals plc?

Avadel Pharmaceuticals plc all-time high TTM earnings before interest & taxes is $102.40M

What is Avadel Pharmaceuticals plc TTM EBIT year-on-year change?

Over the past year, AVDL TTM earnings before interest & taxes has changed by +$68.53M (+107.07%)
On this page